BACKGROUND Mitral annular calcium (MAC), commonly identified by cardiac imaging, is associated with
In observational studies, MAC has been associated with obesity and several metabolic traits, including dyslipidemia (11) (12) (13) (14) . However, whether elevated lipid levels cause MAC and mediate these associations remains unknown. Accordingly, as we have performed previously for aortic valve calcium (15) , we used a Mendelian randomization (MR) approach to evaluate whether a lifelong genetic predisposition to elevations in plasma lipids was associated with the presence of MAC in participants of the CHARGE (Cohorts for Heart and Aging Research in Genetic Epidemiology) consortium. We also utilized several novel MR methodologies to address some of the potential limitations of MR.
METHODS
The CHARGE consortium is an ongoing collaboration among several large, well-phenotyped, prospective, longitudinal cohort studies from the United States and Europe (16) . We evaluated the association of lipid genetic risk score (GRS) with the presence of MAC in CHARGE participants; specifically, white European participants with MAC data by cardiac computed tomography (CT) imaging and genomewide association study (GWAS) data from MESA (Multi-Ethnic Study of Atherosclerosis) and the FHS (Framingham Heart Study), with additional data later added from AGES-RS (Age, Gene/Environment Susceptibility-Reykjavik Study). We also performed cross-ethnicity analyses using MESA Hispanic Americans, the only ethnicity in the MESA study with adequate statistical power for GRS analyses, as there were only 37 cases of MAC among MESA Chinese Americans; the triglyceride GRS, which has not been validated across ethnicities, was also poorly predictive of triglycerides in MESA African Americans (data not shown). Details of each of these cohorts, as well as the CHARGE extracoronary calcium consortium, have been previously described (17) (18) (19) (20) . High-density lipoprotein cholesterol (HDL-C) and triglycerides were measured using standard techniques as previously described (16) . Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation. The studies were approved by relevant regulatory bodies, and participants provided informed consent.
To construct each lipid GRS, we included linkage disequilibrium-pruned single nucleotide polymorphisms (SNPs) that were reported in the 2013
Global Lipid Genetics consortium study (21) to be associated with LDL-C, HDL-C, or triglyceride levels and for which summary results were available in the previously reported GWAS for MAC (10) . As we demonstrated that the results were robust to the meta-analytic model used (i.e., fixed vs. random effects; data not shown).
We performed additional sensitivity analyses using the CHARGE summary-level statistics to address the issue of genetic pleiotropy that could explain the association between triglyceride SNPs and MAC, in which a given SNP might have several biological effects other than its known effects on triglyceride levels. First, we used multivariable MR, a technique that addresses known pleiotropy of included SNPs (26) . Second, we generated 1,000 triglyceride GRS sets randomly excluding 30% of the available lipidassociated SNPs in each set (for LDL-C, HDL-C, and triglycerides). Each lipid risk score was then tested against MAC, and we reported the mean GRS association and the upper and lower 95% CIs for the effect estimate across all 1,000 simulated GRS (15) . Third, we also utilized MR-Egger regression to ensure our results were robust to unknown pleiotropy (27) . cohorts. The prevalence of MAC across the CHARGE cohorts was 20.4% (n ¼ 1,149). To confirm our findings, we also included data from MESA Hispanic Americans (n ¼ 2,025; prevalence of MAC 9.7%).
RESULTS
The ORs per GRS increment for the triglyceride GRS for MAC in the FHS plus MESA cohorts (using combined GWAS summary data) were 2.55 (95% CI: 1.62 to 4.02) and, using individual-level data, the AGES-RS cohort showed an OR of 1.10 (95% CI: 0.67 to 1.79).
In pooled analyses of these CHARGE cohorts, the triglyceride GRS was significantly associated with the presence of MAC (OR per GRS unit: 1.73; 95% CI: 1.21 to 2.41). The LDL-C and HDL-C GRS were not significantly associated with MAC (LDL-C OR per GRS unit: 1.47; 95% CI: 0.96 to 2.27; HDL-C OR per GRS unit:
1.00; 95% CI: 0.68 to 1.48) ( Table 2) . Table 2) . We found no significant association between b MAC and b LDL-C or b HDL-C .
Second, after computing 1,000 triglyceride GRS sets by random SNP exclusions, the association with MAC was largely in keeping with the main analysis, demonstrating no major dependencies of the triglyceride GRS association with any specific SNP or any set of specific SNPs, as seen in Online Figure 1 . Third, MR-Egger estimates, which account for unknown pleiotropy of included SNPs, were also consistent with our main analysis ( Table 2) . In contrast to our prior work examining the genetic determinants of aortic valve calcium, where we identified strong associations with the LDL-C GRS Abbreviations as in Tables 1 and 2 . The development and progression of MAC is now believed to be a tightly regulated process, with marked similarities to bone formation (28, 29) . MAC has been associated with several cardiovascular risk factors including diabetes mellitus, hypertension, and dyslipidemia (11) (12) (13) (14) . In a small case-control study with 107 MAC cases and 107 controls, Nair metastatic calcification (28, 32) . This process has been observed in secondary hyperparathyroidism (33) , which has been associated with obesity and metabolic syndromes, independent of hypovitaminosis D and renal failure (34) (35) (36) . Triglycerides have also been
shown to be correlated with calcium levels (37), which have been attributed to decreased triglyceride clearance in hyperparathyroid states, (38, 39) . However, it remains unknown whether hypertriglyceridemia could also predispose to bone resorption, increased calcium phosphate, or hyperparathyroidism directly.
Although understanding the biological mechanisms for this association will require further study, our Furthermore, MAC is also suggested to cause tethering of leaflets with resultant mitral regurgitation (7). More severe MAC also may predispose to mitral stenosis due to calcium encroachment in the mitral annulus (6, 8) .
Currently, the only effective treatment for MV disease is valve repair or replacement when significant regurgitation and/or stenosis become evident, a procedure that is associated with significant morbidity and mortality (41, 42 compared with the other cohorts will require further study. However, even considering this heterogeneity, our joint meta-analysis (using either fixed or random effects) remained significant. Lastly, the association could not be evaluated in African Americans or Chinese Americans from the MESA cohort because the triglyceride GRS was poorly predictive of triglyceride levels (it was not a valid instrument for circulating triglycerides), and statistical power was very low due to the small sample size available. Nonetheless, in
Hispanic Americans, where the sample size was adequate and the triglyceride GRS successfully predicted triglyceride levels, we were able to confirm this association.
CONCLUSIONS
Genetic predisposition to elevated triglyceride levels was associated with the presence of MAC, a risk factor for mitral regurgitation and stenosis, suggesting a causal association between triglycerides and MV disease. Future studies are required to assess whether reducing circulating triglyceride levels could lower the incidence of clinically significant MV disease.
